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Abstract 
In a previous paper we have introduced a phenomenological model of cell metabolism 
and of the cell cycle to simulate the behavior of large tumor cell populations (Chignola 
R and Milotti E 2005 Phys. Biol. 2 8-22). Here we describe a refined and extended 
version of the model that includes some of the complex interactions between cells and 
their surrounding environment. The present version takes into consideration several 
additional energy-consuming biochemical pathways such as protein and DNA synthesis, 
the tuning of extracellular pH and of the cell membrane potential.  The control of the 
cell cycle - that was previously modeled by means of ad hoc thresholds - has been 
directly addressed here by considering checkpoints from proteins that act as targets for 
phosphorylation on multiple sites. As simulated cells grow, they can now modify the 
chemical composition of the surrounding environment which in turn acts as a feedback 
mechanism to tune cell metabolism and hence cell proliferation: in this way we obtain 
growth curves that match quite well those observed in vitro with human leukemia cell 
lines. The model is strongly constrained and returns results that can be directly 
compared with actual experiments, because it uses parameter values in narrow ranges 
estimated from experimental data, and in perspective we hope to utilize it to develop in 
silico studies of the growth of very large tumor cell populations (106 cells or more) and 
to support experimental research. In particular, the program is used here to make 
predictions on the behaviour of cells grown in a glucose-poor medium: these predictions 
are confirmed by experimental observation. 
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1. Introduction 
Individual tumors are complex biological systems and, in spite of great therapeutic 
advances, many tumors still escape treatment and lead to death. Part of the complexity 
of the problem is a sheer consequence of tumor size: clinicians deal with the 
macroscopic properties of tumors, i.e. masses that may eventually weigh a few 
kilograms – and thus with a number of cells that ranges between 106 and 1013 – and that 
may grow for months or years – with a corresponding number of cell cycles somewhere 
in the range between 100 and 10000. Microscopically, the malignant transformation of 
single cells is a multistep process that involves the modification of several molecular 
circuits which, in turn, modify the cells’ behavior and the relationships between cells 
and the environment [1]. In addition, epigenetic and environmental factors – that 
include cell-cell interactions – also conspire with the bare genetic information to make 
tumor growth a highly variable process with very strong feedbacks [1].  
The highly nonlinear character of the cells’ internal molecular machinery, combined 
with the cell-cell and environmental interactions, with the large number of cells in a 
tumor, and with the extended tumor lifespan, make predictions based on the behavior of 
a single molecular circuit quite haphazard. We are thus in a frustrating situation, in 
which the huge body of detailed knowledge that has been collected in basic research 
areas, such as molecular biology, often seems to be of little or no consequence in the 
clinical management of the disease. 
The availability of powerful computers has already helped bridge the gap between 
observations and predictions in many complex problems, and a few attempts have 
already been made to attack the problem of tumor growth with numerical models (see 
e.g. Refs. [2-4] and references cited therein). Recently we have proposed a numerical 
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simulator of tumor growth [5, 6]: the simulator should eventually reproduce the growth 
of solid tumors in the prevascular phase and allow an in silico investigation of the 
biophysical laws that govern tumor growth dynamics and the response of cell clusters to 
anti-tumor treatments. The program simulates both tumor cells and the complex and 
changing environment where molecules, such as nutrients and drugs, diffuse and where 
cells interact mechanically with one another. The simulator deals with very different 
spatiotemporal scales and eventually with a large number of cells; using the prototype 
software we have been able to achieve a linearization of time and memory requirements 
using techniques and methods borrowed from molecular dynamics and computational 
geometry [5]. An essential part of the simulation software includes the code for 
metabolism and cell cycle, and in a previous paper we have shown and discussed the 
basic aspects of the underlying biophysical model [6]. Here we refine and extend that 
code and show that it can be used to simulate the proliferation of tumor cells that grow 
in a closed environment with good quantitative agreement with experimental data. We 
also use the model to predict the behavior of cells that grow in non-standard 
environments and compare these predictions with actual experimental data. 
The next section briefly describes the materials and methods used in the experiments 
that have been carried out to fix some of the necessary parameters and in the numerical 
simulations. Section 3 contains a detailed description of the simplified metabolic 
network included in the simulator, and section 4 explains the implementation of the cell 
proliferation dynamics. The results of the simulations and comparisons with 
experimental data are given in section 5, while section 6 contains our conclusions and 
our outlook on future developments. 
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2. Materials and methods 
 
2.1 Cell lines and proliferation assays 
Molt3 (human T cell leukemia) and Raji (human B cell leukemia) were obtained from 
the ATCC and maintained in RPMI-1640 medium supplemented with 10% foetal 
bovine serum. Cells were cultured at 37 °C in a 5% CO2 humidified atmosphere and 
passaged weekly. For proliferation assays, 15x104 cells from exponentially-growing 
cultures were seeded into T25 culture flasks in 7 ml of the following media: complete 
RPMI-1640 + 10% FBS or glucose-deprived RPMI-1640+10% FBS. Fifty 1 μl samples 
were drawn from culture flasks at the time point indicated in the figures to carry out 
measurements of cell survival. Alive and dead cells were identified using the vital dye 
Trypan-blue and were counted at the microscope using a Neubauer chamber. Four 
measurements for each well were carried out and the values were then averaged. Each 
data point in the growth curves is the mean ± standard deviation (SD) of three 
independent replicates. The amount of ATP in growing cell populations was measured 
using the luciferine/luciferase method (Promega kit) following the manufacturer's 
procedures. Measurements expressed in luminescence arbitrary units were converted to 
concentration units by means of a calibration curve obtained with known amounts of 
ATP. Luminescence was measured using a microplate luminometer reader (Bio-Tek 
instruments). Each data point in the figures is the mean ± SD  of eight independent 
replicates. 
Cell cycle analysis was carried out by flow cytometry. Cells were washed with PBS, 
and cell pellets produced from 1.5x105 cells where resuspended under mild vortexing 
with 1 ml of cold Tris/HCl-EDTA buffer (0.1 M Tris-hydroxymethyl-aminoethane, 1 
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mM EDTA, pH 7.4). Cells were centrifuged at 4 °C and supernatants discarded. Pellets 
were labelled with 1 ml of a cold ethidium bromide solution (25 μM ethidium bromide, 
0.3 mM Na-citrate, 1 mM NaCl, 0.1% v/v Triton X-100, 25 μg/ml RNAaseA) under 
mild vortexing, and cells incubated overnight at 4 °C . The nuclei were analyzed by 
flow cytometry on an EPICS-X (Coulter, Hialeah, FL) flow cytometer using a 
preparation from human peripheral blood mononuclear cells (blood drawn from healthy 
donors) as the standard. 
 
2.2 Simulations 
The simulation program has been written in ANSI/ISO-C++ and has been run on Apple 
computers (both PowerPC- and Intel-based). The program has been compiled with the 
GCC 4 compiler in a Mac OS X environment. The differential equations that make up 
the model have been integrated with a fixed time step t = 1 s; this choice is dictated by 
the conflicting needs of reducing the total computation time as much as possible and by 
the computational request - needed for algoritmic stability - that t << k for all the 
Michaelis-Menten (MM) reactions, where k is the reaction time constant for low 
concentrations for the kth MM reaction. The model is partly stochastic, and 
pseudorandom numbers have been generated by the linear congruent generator RAN2, 
taken from the Numerical Recipes library [7]. 
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3. A minimal model of the biochemical network of tumor cells 
 
The biochemical network implemented in the simulation program is shown in Fig.1: it 
is a really minimal network in comparison to the complexity of the actual metabolic 
system of tumor cells. The rationale behind the choice of the reactions in this minimal 
set has been discussed extensively in our previous paper [6], and we summarize again 
here the main arguments: 1. many parameters of the metabolic network are actually 
unknown; 2. even if we had a detailed knowledge of the actual metabolic network, a 
numerical model of a single cell’s metabolic network would be computationally heavy, 
and the simulation of large cellular ensembles would be extremely impractical [5]; 3. 
many metabolic pathways are redundant and, in addition, it is now clear that the whole 
system has a hierarchical topology and that its dynamical behavior is dominated by the 
network’s hubs [8]. We have thus decided to keep only those metabolic pathways that 
in our opinion do determine the cell’s behavior: obviously this choice is somewhat 
arbitrary but it is eventually validated by the comparison with the experimental data. 
The core of the metabolic network in Fig.1 contains the uptake and conversion of 
glucose and of other molecules into energy (in the form of ATP), storage molecules 
(e.g. glycogen) and waste products (e.g. lactate) and hence this part of the model is a 
global representation of glycolisis, oxidative phosphorylation through the TCA cycle 
and gluconeogenesis. Certain pathways are controlled by sensors, and we have 
considered both ATP and oxygen sensors. These sensors depend on the biophysical 
state of the virtual cell and tune its behaviour when ATP and/or oxygen become limiting 
factors because of harsh environmental conditions. All these aspects and their 
mathematical modeling have been described and discussed in our previous paper [6]. In 
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the following subsections we concentrate on the new pathways that we have included to 
model growth in a closed environment. The values of model parameters for these 
pathways are listed in table 1. Since the environment is now closed it follows that we 
have to consider a conservation equation for the whole system's volume and a detailed 
description of the transport kinetics of some chemical species (like nutrient and waste 
products) inside and outside cells. But this, in turn, implies that the fate of the certain 
chemical species in cells must also be described and hence biosynthetic pathways that 
were previously neglected [6] must now be taken into consideration. We include also 
protein and DNA synthesis and since these paths consume energy the global energy 
balance of the cell must also be extensively revised as well. 
 
3.1 Closed environment 
The first significant biophysical difference with respect to our previous model is the 
definition of the closed environment where cells grow. In the previous version, in fact, 
cells were assumed to grow in an open volume where nutrients were always available 
and waste products immediately removed [6]. Now the environment is closed – as it 
happens to be in most experimental settings and in real tumors embedded in animal 
tissues – and environmental concentrations of nutrients, waste products, and other 
molecules become importantant variables. Because of the negligible compressibility of 
water solutions the environmental volume is effectively constrained by the equation : 
Voltot = Volenv + Volk
k=1
N
 = constant        (1) 
where Volenv is the volume of the extracellular environment and Volk is the volume of 
the k-th cell.  
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3.2 The pool of “other nutrients” in compartment A: glutamine as an essential 
component 
In our previous work [6], we introduced compartment A (see Fig.1) to include nutrients 
other than glucose that can nonetheless be catabolized through the oxidative 
phosphorylation pathways or converted into storage molecules through 
gluconeogenesis, and indeed it is known that tumor cell metabolism does not rely on 
glucose only. Since numerous but different molecules – each one involving different 
enzymatic mechanisms – can partecipate in cell metabolism, energy production and 
storage (in the form of glycogen, through the gluconeogenesis pathway that is described 
here phenomenologically by means of rate p11 – see Fig.1), we initially considered 
compartment A as a generic pool of “other nutrients” (e.g. lactate, glutamine and other 
aminoacids).  However, in the present version of the model we also want to include 
biosynthetic pathways such as protein and DNA synthesis that are intimately linked to 
cell cycle kinetics (see the next paragraphs),  and thus we need a better definition of the 
nutrients in the A compartment. We have decided to narrow the scope of the A 
compartment and focus on glutamine alone for the following reasons:  
1. it is well known that glutamine is essential (together with glucose) to sustain tumor 
cell growth in vitro [9,10], and is required by real tumor cells in vivo [9,10], and it has 
also been shown that glutamine utilization for ATP production through the oxidative 
phosphorylation in tumor cells may actually overcome that of glucose [11];  
2. it has been reported that most, if not all, tumor cells express the glycolytic isoenzyme 
pyruvate kinase type M2 (M2-PK) and that this enzyme is not expressed by normal cells 
[12]. The enzyme occurs in a highly active tetrameric form and in a dimeric form with 
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low affinity for phosphoenolpyruvate. The switch between the two forms regulates 
glycolytic phosphometabolite pools and the interaction between glycolysis and 
glutaminolysis, the latter resulting in pyruvate and lactate production from glutamine 
[12]. Thus, these pathways do depend on glutamine (although the correlation depends 
on a series of enzymatic reactions) and this justifies the phenomenological description 
represented by rates p22 and p11, respectively (see Fig.1);  
3. Finally, glutamine is an essential building block both of proteins and of DNA (see 
below) [13,14]. 
 
3.3 Transport of nutrients and of waste products across the cell membrane 
Except for oxygen which diffuses freely across the cell membrane, transport of glucose, 
glutamine and lactate is mediated by saturable transporters whose activity is well known 
to follow a Michaelis-Menten type kinetics. Thus, if Xin and Xout represent the 
concentrations of a given molecule in the cell and in the environment, then transport 
across cell membrane is modelled by the equations: 
 
dXin
dt
=  dXout
dt
= vinout  voutin        (2a) 
voutin =
vmaxXout
Km + Xout
         (2b) 
vinout =
vmaxXin
Km + Xin
         (2c) 
vmax = vm Surf          (2d) 
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where vm and Km are the Michaelis-Menten constants for the molecular transport and 
Surf is the cell surface area. The transport of glucose depends on the oxygen 
concentration as well, and this dependence, along with the value of model parameters 
for glucose transport, has already been described [6]. 
 
3.4 Intracellular and extracellular pH. Dependence of various transport and metabolic 
rates on environmental acidity.  
The intracellular and the extracellular pH are assumed to vary primarily because of 
lactate production. Lactic acid is produced by cells during the conversion of glucose 
through the anaerobic glycoslysis. During this conversion ATP is also produced, and 
from the stechiometry of ATP and lactic acid production we know that 2 moles of both 
species are produced per mole of glucose. Thus, the production rates of both species 
(see ATP_nOX in Fig.1) also match and have been parametrized by means of the rates 
g1 and r1 (see Fig.1) that describe the conversion of glucose-6-phosphate (G6P) and of 
glycogen storage molecules (STORE) through glycolysis (see [6] for further details). 
Within the range of acidity that is physiologic for living cells, lactic acid is completely 
dissociated into lactate- and H+ ions and these are co-transported through the cell 
membrane by means of MCT transporters. The MCT transporters do not require energy 
and transport proceeds bidirectionally along the lactate and proton gradients [15]. In a 
cell, protons partecipate to a complex series of chemical equilibria that regulate several 
important processes such as the cell osmotic pressure, the potential of the cell 
membrane and of the membranes of intracellular organelles (e.g.  mitochondria), the 
transport of various ions across the cell membrane and the production of energy under 
the form of ATP. The regulation of the intracellular pH involves the action of  energy-
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driven proton pumps (H+ ATPase), proton channels and ion transporters that drive H+ or 
equivalent H+ and HCO3
- ions into and out of the cell and that are all expressed at the 
cell membrane [16]. The latter include an Na+/H+ antiport, Na+-dependent HCO3- 
transporters, an Na+-independent Cl-/HCO3- exchanger, an Cl-/OH- exchanger and other 
transporters such as the lactate-proton cotransporter [16]. In addition, a number of 
chemical reactions among which the set of reactions describing the buffering effect of 
the carbonate/bicarbonate system takes place both in the cellular cytosol and in the 
environment. Taken as a whole this system is rather complex (see e.g [17,18]) and 
includes fast chemical reactions, faster than the time interval of 1 s that we have taken 
as a compromise between algoritmic stability, computation time and computational 
load.  
However some simplifications are possible: firstly, the experimental evidence shows 
that the buffering capacity of cytosol in tumor cells is much higher than that of the 
surrounding environment. Although the intracellular buffering capacity has been shown 
to vary slightly during the cell cycle, the intracellular pH does not vary much during the 
cell’s life and this is due to the number of proton and ion pumps and of buffering 
systems that a tumor cell expresses and exploits for this purpose [19]. In addition, using 
a parametrization of the observed buffering capacity of cytosol [20], we carried out 
numerical simulations that demostrate that intracellular pH in simulated cells falls 
below physiologic limits only under severe starvation, that would anyway lead to cell 
death, e.g. because of insufficient ATP or glycogen storage levels. Thus, as a first 
approximation, we have assumed intracellular pH to be constant and we have fixed it at 
7.2, which is the observed value in tumor cells [16,19,20]. Another simplifying 
consideration is that the buffering capacity of the environment can be measured quite 
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easily, and for standard culture media the pH has been shown experimentally to be 
directly proportional to environmental lactic acid concentration [21]. In the simulator 
we take the following phenomenological model for the acidity of the extracellular 
environment: 
 
pHout = pHst 
AcLout
Volout  out
   (3a) 
out = 
dHout
dpHout
    (3b) 
 
where pHst is the standard pH of a clean medium, AcLout is the mass of lactate in the 
extracellular environment, Volout is the volume of the environment (and thus 
AcLout Volout  is the lactate concentration in the environment) and out is the buffering 
capacity of the environment estimated from experiments [21]. 
The Michaelis-Menten parameter vmax for the transport of glucose, lactate and of other 
molecules (see below) is known to depend on pH [22-25]. To the best of our 
knowledge, however, this dependence has not been studied in detail and no firm 
biophysical conclusions are available. Once again we resort to a phenomenological 
description that nonetheless takes into account the results of experimental observations. 
This description assumes that the vmax of the various transporters is weighed by a 
function which is roughly a sigmoid curve as a function of pH. In practice we take the 
piecewise linear approximation for the weight function:  
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w pH( ) =
w1 pH < pH1
w1 +
w2  w1
pH2  pH1
pH  pH1( ) pH1  pH  pH2
w2 pH > pH2






   (4) 
 
where w1, w2 , pH1, pH2 are the parameters that we specify to approximate the few 
available data.  
In particular, for the transport of glucose and of glutamine we take w1 = 0 , w2 = 1 , 
pH1 = 6.3 , pH2 = pHst = 7.54  (see [22,25]), while for lactate transport, we take 
w1 = 3, w2 = 1 , pH1 = 6.0 , pH2 = 8.0  [23,24].  
It should be noted that since the intracellular pH is kept at a fixed value, then the flow 
of glucose, glutamine and lactate is unbalanced if the environmental pH differs from the 
standard value, and in the closed environment described by the simulator this does 
indeed happen because of lactate production and secretion by cells. As the environment 
is gradually more and more acidic, the uptake of nutrients is also reduced and can 
eventually switch off completely, thereby leading to a depletion of the energy reserves 
and ultimately to cell death. This mechanism, which is entirely mediated by the weight 
function described above, represents an important feedback regulatory circuit between 
cells and their environment, and can be tested experimentally because it defines the 
carrying capacity of the environment where cells grow (see the results section). 
We take a fixed intracellular pH, however the increase of the concentration of H+ ions in 
the cells cannot be neglected. The increase is originated by two main processes: as the 
cell population grows the lactic acid secretion also rises and the environmental pH 
lowers below the standard intracellular level: in this case a cell can import lactic acid 
through the MCT transporters. Secondly, the continuous intracellular production of 
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lactic acid may eventually overcome the maximal rate of secretion of MCT transporters. 
We have already remarked that  H+ ions partecipate in a number of cellular processes in 
tumor cells, that collectively allow cells to maintain an almost fixed pH [16] and that 
these processes can be subdivided into two categories on the basis of their energy 
requirements. Since the energy consuming pathways are important in our model, we 
must take into account the consumption of ATP used to eliminate intracellular H+ when 
the MCT transporters alone cannot sustain the whole load. It should be noted that we 
are not interested in the fate of the H+ ions, because of the phenomenological modeling 
of  the intracellular and extracellular pH, and we only need to focus our attention on the 
energy balance of H+ transport. 
To model the energy consumption due to H+ transport, we recall that in the model H+ 
ions originate from the complete dissociation of lactic acid, and that lactic acid is 
synthesized by cells through glycolysis and this path is described by rates g1 and r1 (see 
Fig.1; see also [6] for details). In addition lactic acid is transported out and in the cells 
by means of the MCT transporters with a transport kinetics that follows the set of 
equations (2a-d). H+ can finally move across cell membranes by passive diffusion. The 
mass variation of H+ ions in the cell therefore writes: 
 
dH +
dt
= (2g1 + 2r1 + voutin,AL  vinout ,AL ) 
MW
H +
MWAL
+ D
H +
 H + out  H
+ in( )  (5) 
 
where the factor 2 takes into accounts the stechiometric result that 2 moles of lactic acid 
are produced per mole of glucose, vpAL and vmAL are the rates of lactic acid transport in 
and out of the cells through MCT transporters, MWH
+ and MWAL are the molecular 
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weights of H+ and lactic acid, respectively, DH
+ is the effective diffusion constant (i.e. 
the diffusion coefficient multiplied by the thickness of the cell membrane) of H+ in the 
cell membrane and [H+]out, in are the extracellular and intracellular H
+ concentrations, 
respectively. Equation (4) is then used to calculate the energy consumption required to 
move the charged ions in the electric field associated to the Nernst membrane potential 
when this field opposes H+ secretion (see below). 
 
3.5 Protein and DNA synthesis 
Protein synthesis and DNA synthesis are two important new blocks in the present 
simulation program, however the very high complexity of the actual cellular processes 
means that once again we have to resort to some form of approximate 
phenomenological description. In the case of protein synthesis we compute the number 
of glutamine and ATP molecules required to build an “average protein”. We take 
human serum albumin as a representative of the “average protein”; albumin contains 
585 aminoacids and its molecular weight is  66.4 KDa [26]. Glutamine is incorporated 
in the protein as it is or after it has been changed into another aminoacid by enzymatic 
modification of its sidechain. Experimentally, it has been shown that in the proteins of 
HeLa tumor cells the aminoacids Ala, Asp, Glu, Gly, Pro, Ser derive from the 
glutamine carbon sidechain, although to a different extent [13]. For example, as much 
as 68% of Asp but only 3.2% of Ser derive directly from glutamine [13]. From these 
quantitative data and from the sequence of human albumin, we estimate that, on 
average, 5% of albumin aminocids are glutamine or are derived from glutamine. Thus, 
to synthesize one molecule of an average protein of 585 aminoacids the cell needs on 
average 29.25 glutamine molecules as building blocks.   
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An average protein of 585 aminacids contains 584 peptide bonds that require the 
hydrolysis of 2 molecules of ATP and 2 of GTP per bond for formation [27], and hence 
1168 ATP molecules are utilized on the whole to synthesise one molecule of the 
average protein (note that in the present model the GTP molecular pathways are not yet 
taken into account).  
Protein synthesis requires both glutamine and ATP as building blocks, and since either 
of them can vary in time and become a limiting factor, the rate of protein synthesis must 
depend on the building block which, at any given time, is less abundant (at the moment 
we neglect recovery of aminoacids due to protein degradation). From these 
considerations we find the equations that model protein synthesis: 
 
dPs
dt
=
p33
29.25
 MWPs
MWA
         if   
NATP
1168
>
NA
29.52
dPs
dt
=
vp
1168
 MWPs
MWATP
        elsewhere 






     (6a) 
p33 = p3 d            (6b) 
vP =
ATP _TOT  ATPp
KmP + ATPp
        (6c) 
 
where PS is the protein mass, NATP and NA are the numbers of available ATP and 
glutamine molecules, respectively, MWPs, MWATP, MWA are the molecular weights of the 
“average protein”, ATP and glutamine, respectively, vP is the rate of ATP pool 
consumption for protein synthesis (this is assumed to follow a Michaelis-Menten 
kinetics because of the activity of the enzymes that utilize ATP for protein synthesis), 
ATP_TOT is the total ATP production (see [6] for details), KmP is the Michaelis-Menten 
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constant for ATP consumption, p3 is the rate of glutamine molecules channeled to 
protein synthesis and d is a homeostatic control function that assumes real values in the 
interval [0,1] and that modulates the rate p33 as a function of the size of the glutamine 
compartment A (see [6] for details). Initial guesses for p33 and vp were obtained by 
considering that the protein content of one cell is approximately 10-20 % of the cell's 
mass [27], that a cell has a relative density  1 and that at the end of one cell cycle the 
protein mass must be approximately twice as much as in a newborn cell.  
We have modeled DNA synthesis much like protein synthesis. However, in this case we 
note that the atoms N3 and N9 of purines and N3 and C2 of pyrimidines derive from the 
sidechain of glutamine after some biochemical processing [14, 27]. Thus, on average 
the stechiometric relationship between glutamine and the bases of the DNA is one 
molecule of glutamine for each base. We also note that the number of bases in the 
human genome is 6x109, and that the incorporation of nucleotides into the DNA 
sequence is sustained energetically by the hydrolysis of the high-energy phosphoryl 
groups present in the nucleotides themselves. The formation of the phosphodiester 
bonds (G=5.3 Kcal/mol) – that join one base to the other  – requires energy that is 
provided by ATP, then if we assume that during the duplication of the genome 
approximately 6x109 phosphodiester bonds are formed and that the hydrolysis of ATP 
releases  11.94 Kcal/mol [27], we can estimate that DNA duplication requires  
2.67x109 ATP molecules. Thus both glutamine and ATP are required for DNA 
synthesis, and both may vary during the cell’s life and limit the DNA synthesis rate, 
which we model as follows: 
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dDNA
dt
=
p33
6 109
 Nav
MWA
         if   
NATP
2.67 109
>
NA
6 109
dDNA
dt
=
vDNA
2.67 109
 Nav
MWATP
        elsewhere 






    (7a) 
vDNA = DNA 1+ DNA_MAX_SPREAD·( )
ATP _TOT  ATPp
KmDNA + ATPp
   (7b) 
 
where vDNA is the rate of ATPp consumption for DNA synthesis, Nav is the Avogadro 
constant, DNA is the fraction of the total ATP production rate ATP_TOT that is 
channeled to DNA synthesis in the S phase of the cell cycle, KmDNA is the Michaelis-
Menten constant of the enzymatic process of ATP utilization for DNA synthesis, 
DNA_MAX_SPREAD is a constant, and  is a random variable drawn from a uniform 
distribution on the interval (-1,1). The term DNA_MAX_SPREAD* is small cell-
dependent random spread which is determined at cell birth and it has been introduced to 
parametrize the fluctuations assumed to occur in certain mechanical aspects of DNA 
synthesis that involve processes such as the unidirectional translocation of the motor 
proteins helicases to unwind and separate the two DNA strands [27]. Finally, it should 
be noted that we consider only one rate term for glutamine utilization for both protein 
and DNA synthesis. In this way the glutamine pool (compartment A in Fig.1) is 
subdivided into three pools that sustain the STORE compartment (p11), energy 
production (p22) and biosynthesis (p33) and where p11 and p22 are dynamically 
interconnected through the ATP sensor (see also [6] for details).    
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3.6 The energy balance: summary of the energy producing and consuming processes 
The model of cell metabolism takes into account diverse energy producing and 
consuming pathways. Energy, stored under the form of ATP, is produced by anaerobic 
glycolysis (rate ATP_nOX in Fig.1) and oxidative phosphorylation of glucose taken up 
from the environment (rate ATP_OX in Fig.1). In addition, if ATP_OX falls below a 
standard ATP production rate (e.g., under starvation conditions), a cell senses this 
difference and channels glycogen and glutamine catabolites toward oxidative 
phosphorylation to produce ATP (rates ATP2 and ATP3, respectively, in Fig.1). 
However, the production of glycogen molecules through gluconeogenesis has a cost that 
has previously been modeled by the rate ConsATP [6]. These paths have been discussed 
in detail earlier [6] and led us to define an overall production rate ATP_TOT and an 
overall balance between energy producing and consuming pathways, as in the following 
equations: 
 
ATP _TOT = ATP _nOX + ATP _OX + ATP2 + ATP3 ConsATP    (8a) 
dATPp
dt
= ATP _TOT  rc         (8b) 
 
where ATPp is the ATP pool and rc is a phenomenological ATP consumption rate. One 
of the main differences between the previous model and the present one is that now we 
define some of the energy consuming paths that were previously modelled by means of 
the single phenomenological rate rc. In this context, we have already described above 
the use of ATP for protein and DNA synthesis. In addition we also consider a 
phenomenological rate of ATP consumption for mitochondria maintenance (i.e., 
maintenance of the mitochondria membrane potential which is essential for 
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mitochondria to work properly [28], see vMit in Fig.1) which is proportional to the 
number M of mitochondria in the cell. Finally, we include in the model the consumption 
of ATP used to pump H+ ions outside the cell when the environmental pH becomes 
lower than the intracellular pH. The latter has been calculated as follows: we assume 
that, under normal environmental conditions, the cell has a membrane potential      
Vrif = -21 mV (derived from calculations using the Nernst equation and assuming that 
the standard extracellular pH is 7.54 and the intracellular pH is 7.2, see below and [16]). 
When the concentration of environmental H+ increases – because of lactic acid 
production and secretion – the membrane potential changes according to the Nernst 
equation: 
 
VNernst =
R T
z F
 ln [H
+ ]out
[H + ]in
        (9) 
 
where R is the the gas constant, T is the temperature (°K), z is the proton charge and F 
the Faraday constant. Under standard condition, the environmental pH is set to 7.54 and 
the intracellular pH to 7.2, so that VNerst=Vrif= -21 mV. As long as the environmental pH 
is greater than the intracellular pH, H+ ions diffuse passively through the cell membrane. 
However, with a higher extracellulary acidity, H+ ions cannot longer diffuse and must 
be actively pumped outside the cell: the energy required to pump H+ ions outside the 
cells can be calculated from the Gibbs energy of ATP hydrolysis (GATP = 3.1x104 
J/mole) and the energy required to move a charged particle across the electric potential 
difference V=Vrif-VNernst. The rate of ATP consumption is:  
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vATP _ H = H _Peff 
dH +
dt
 F  V
GATP
MWATP  103
mole
kg




    (10) 
 
where H_Peff is a constant that parametrizes the efficiency of the H+ pumps, the rate 
dH +
dt
 has been defined in equation (4), MWATP is the molecular weight of ATP and the 
multiplicative factor 103
mole
kg
 is the conversion factor that is needed to express the 
result in SI units (i.e., one mole of H+ weighs 0.001 kg), so that vATP_H, the rate of ATP 
consumption for proton secretion against the electric potential, is expressed in kg/s as 
all the other rates. 
Overall, the balance between energy production and consumption writes: 
 
dATPp
dt
= ATP _TOT  (vP + vDNA + vMit  M + vATP _ H )     (11) 
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4. Cell proliferation dynamics 
 
In this section we describe how the model of cell metabolism is integrated with the 
biochemical network that drives the cell cycle and cell growth, and in particular we 
describe how we link the metabolic network to growth and division, i.e. the mechanism 
of molecular threshold implemented in the simulator. Next, we discuss the sources of 
randomness in the dynamics of cell division that are important in the simulator, and 
finally we list criteria for cell death. 
The proliferation dynamics presented here differs in many ways from the dynamics in 
the previous version described in [6] and hence some preliminary comments are in 
order. First of all, the control of cell progression along the cell cycle was previously 
modeled by means of phenomenological thresholds. The cell cycle is conventionally 
represented by a series of phases characterized by specific molecular events and there 
are four major phases that cells traverse from birth until duplication: the initial growth 
factor-dependent phase G1, the S phase where DNA duplication takes place, the G2 
phase during which a cell prepares its genetic material for proper sorting into the two 
daughter cells and the M phase were duplication (mitosis) occurs. Passage from one 
phase to the other is a unidirectional and highly coordinated process which is regulated 
in particular by a class of proteins called cyclins: the different members of the class are 
expressed at specific points along the cell cycle and activate kinases, the cyclin-
dependent kinases (CDKs) [29]. Active CDKs, in turn, phosphorylate specific protein 
substrates often on multiple sites, and these phosphorylation events are tuned by a 
network of proteins, inhibitors and enzymes that phosphorylate or dephosphorylate the 
proteins involved, among which the CDKs themselves [29]. The result is a complex 
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enzymatic network with feedback regulatory circuits that regulates the progression of a 
cell from one phase to the next at specific points called cell-cycle checkpoints [29]. This 
network has a fundamental relevance for both normal and tumor cell growth, and 
various models of its inner workings have been proposed [30]. 
The control of the progression along the cell cycle ultimately consists in the activation 
of kinases which phosphorylate substrates using ATP as the donor of high energy 
phosphoryl groups [29], therefore ATP depletion can be expected to block cell growth, 
and indeed the existence of two energetic thresholds at the G1/S and G2/M transitions 
has been demonstrated for tumor cells [31,32]. In our previous model we included only 
a rough description of these thresholds [6]. However, in a recent study of the dynamic 
properties of the multisite modification of proteins we have shown how this mechanism 
may apply to proteins that are central to the cell cycle checkpoint mechanism, and how 
it can set a biochemical threshold [33, 34]. The threshold obtained from multisite 
modification is robust and depends on the concentrations of all the molecules involved 
in the reaction, i.e., the checkpoints depend non only on the ATP concentration, but also 
on the concentrations of enzyme and substrate, and may better account for the observed 
variabilities of the cell cycle [33, 34]. 
A second major difference is the link between energy production and cell growth: the 
increase of cell volume was previously assumed to be proportional to the net uptake of 
glucose and to the overall rate of energy consumption [6]. The idea was that glucose 
uptake and storage provide a source of carbon atoms and that at the same time the cell 
mass increase can only proceed with a corresponding energy expense. Thus we 
considered a net balance of glucose uptake and storage given by a linear combination of 
the rates v1p, v1m, g1 and g2 [6], while energy consumption was modeled by means of the 
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phenomenological rate rc discussed above. The rate rc described the global ATP 
consumption in processes such us protein and DNA synthesis, tuning and maintenance 
of the membrane potential and so forth, which, however, were not explicitly included in 
our previous model [6]. Unfortunately this description has a logical fault: ATP 
consumption depends on the amount of available ATP that in turn depends on cell 
metabolism where molecules such as glucose itself are converted into energy, and thus 
glucose uptake and ATP consumption, and hence energy consumption, are directly 
correlated, while they need not be. In addition, the hypothesis that cell volume increases 
as a function of energy consumption is biologically untenable since this does not 
consider possible dissipative pathways that are not related to cell growth, such as active 
secretion of newly synthesized proteins.  Since we make explicit several energy 
consumption paths we must revise the link between cell metabolism and cell growth.  
 
4.1 Linking the metabolic network to the cell cycle 
In this subsection we summarize the conditions that each cell must satisfy to step from 
one phase to the next in the simulator, and we start with the most complex mechanism, 
which is responsible for the G1/S phase transition. The G1/S checkpoint is perhaps the 
best known and the most important one, because as soon as cells pass the checkpoint 
they become committed to progress along the remaining part of the cell cycle [35, 36]. 
The molecular details have been reviewed in several papers (see e.g. [35-40]).  
Central to the underlying molecular network is the Rb/E2F complex. The 
retinoblastoma protein Rb (pRb) has 16 putative phosphorylation sites and may exist in 
various forms depending on the level of phosphorylation [37-40]. In its 
hyperphosphorylated form, when at least 10 sites are phosphorylated [37-40], the 
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Rb/E2F complex is fully dissociated, but partial dissociation may occur for intermediate 
phosphorylation levels of the Rb protein. E2F is a transcription factor that once 
dissociated from the pRb starts the transcription of genes involved in a series of 
important pathways that ultimately bring about DNA synthesis [35-40]. This 
checkpoint, therefore, marks the end of the G1 phase and the beginning of the S phase. 
The phosphorylation of the Rb protein takes place thanks to the coordinated action of at 
least two different cyclin-dependent kinases (CDKs) that, in turn, are activated by 
cyclin D and cyclin E. These cyclins are expressed at appropriate phases of the cell 
cycle – in particular the expression of cyclin E is controlled by E2F after it is released 
by pRb upon partial phosphorylation – and form complexes with the specific CDK’s.  
The CDKs’ concentration in the cell is rather constant throughout the cell cycle, thus 
the timing of the CDKs’ action is determined by the expression of the cyclins [29]. The 
enzymatic activity of the CDKs is also tuned by phosphatases and inhibitors that 
collectively form a complex biochemical network with feedback regulatory circuits [29, 
30]. The network has already been modeled, and it has been shown that important 
dynamical behaviors emerge: thresholds, hypersensitive response and hysteresis [41]. In 
other words, the network reacts as an on-off irreversible switch [41]. 
Here we apply once again the approach that we followed in the case of cell metabolism: 
just as the metabolic network, the checkpoint control network has a hierarchical 
structure, and we assume its dynamics to be dominated by the system's hubs. Given its 
demostrated importance [35-40], we have selected the multiple phosphorylation process 
of the Rb protein as the central hub of the checkpoint control network. We have isolated 
this process from the network (Fig.2) and studied the general dynamical properties of 
the modifications of proteins on multiple sites (multisite protein modification, MPM) 
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[33, 34]. The results have been published recently and here we summarize the main 
conclusions:  
1. MPM naturally produces a threshold in the system’s response;  
2. the threshold is robust to noise perturbation, and this is important when dealing with 
low protein concentrations, that is to say when fluctuations are not negligible;  
3. if the protein that carries multiple modification sites controls a downstream 
Michaelis-Menten reaction (Fig.2), then MPM delays the downstream reaction and the 
delay may be several orders of magnitude larger than the characteristic times of enzyme 
kinetics. Thus MPM drives the information transfer from the fast kinetics of enzymes 
action to the slow kinetics of cellular response;  
4. MPM dynamics does not depend on the attachment/detachment mechanism of the 
chemical groups (i.e. phosphoryl groups) that modify the protein with multiple 
modification sites and these may be represented by enzymatic processes or simplified as 
bimolecular interactions. It follows that MPM is equivalent to the classical allosteric 
effect [33, 34] and that, to model its dynamics, one can neglect the specific processes of 
protein modification.  
The dynamical properties of MPM are rather attractive because they allow great 
simplification of the model of the G1/S checkpoint. In particular from property 3. we 
can represent the duration of the G1 phase in terms of an enzymatic reaction controlled 
by a protein with multiple modification sites and this is reminiscent of the way E2F 
drives the transcription of genes once released by the Rb control protein. Moreover 
properties 1. and 2. assure that the dynamical response behaves like a robust on-off 
switch, and property 4. justifies an approximate description. 
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The basic model for the control of the G1/S transition in our virtual cells is shown in 
Fig.2 and is based on the following assumptions: 
1. the amount of ATP required to phosphorylate the Rb protein is negligible with 
respect to the overall amount of available ATP in the cell that is described in our model 
by the variable ATPp; 
2. CycD and CycE instantaneously form complexes with specific CDKs whose 
concentration is constant during the cell cycle. As soon as the complex is formed the 
phosphorylation of the Rb protein starts; 
3. the phosphorylation/dephosphorylation events of the individual available sites on the 
Rb protein follow a stochastic dynamics and are fast with respect to the observation 
time (i.e. with respect to CycD and CycE expression rates). 
With these assumption we can describe the process of pRb phosphorylation by means of 
a probabilistic chain of phosphorylation/dephosphorylation events (transition chain) that 
occurs as a consequence of classical bimolecular reactions between cyclins and pRb 
[33, 34]. In particular, using assumption 3. we can neglect the dynamics of the transition 
chain  and even the chain itself and concentrate instead on the equilibrium probabilities. 
The analysis in [33, 34] shows that if the E2F is released when at least nth = 10  sites on 
pRb are phosphorylated, then we find the number of free E2F molecules: 
 
PRb = NRb 
N
n



	
 pn  (
n=nth
N
 1 p)N n        (12a) 
p =
1
2N[Rb]
 N[Rb]+ [Cyc]+ KRb( )  N[Rb] [Cyc]( )
2
+ 2KRb (N[Rb]+ [Cyc]) + KRb
2{ }
           (12b) 
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where PRb is the number of activated pRb molecules with at least nth phosphorylated 
sites out of a total of N sites,  NRb is the total number of pRb molecules, KRb is the ratio 
between backward and forward rate constant of phosphorylation supposed to occur in a 
bimolecular reaction between the cyclin/CDKs complexes (CycD and CycE) and pRb, 
[Cyc] = [CycD]+ [CycE]  is the total cyclin concentration, and where the square 
brackets denote concentrations. 
A recent, more detailed analysis of the process dynamics has confirmed that it is safe to 
use the quasi steady-state assumption [34]. 
The number of activated pRb molecules depends on the concentrations of pRb, CycD 
and CycE. Using data in the current literature we assumed a phenomenological model 
for the kinetics of the three proteins as a function of the cell cycle phase [29, 35-40], 
and the results are shown in Fig.3. In this scheme, the Rb protein has been hypothesized 
to be synthesized in the G2 phase and then to be partitioned randomly at mitosis 
between the two daughter cells (see the next paragraph for a further discussion on this 
point). As far as we know, experimental evidence on the precise timing of the pRb 
expression is not available. Existing data indicate that the protein maintains an almost 
constant concentration in the cell but varies both its phosphorylation state and 
intracellular localization [29, 35-40]. Since cell division would result in a dilution of the 
pRb concentration the protein must be synthesized de novo sometime during the cell 
cycle of the mother cell. For the model described by the set of equations (12a-b) it is 
only important that pRb molecules are available for a new phosphorylation cycle in the 
daughter cells at the beginning of their life, hence the precise timing of pRb expression 
is irrelevant. On the other hand, CycD is synthesized at the beginning of the cell's life in 
the G1 phase and is destroyed immediately after the cell has overcome the G1m/G1p 
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transition (see also Fig.2); CycE is synthesized in the G1p phase and is destroyed as 
soon as a cell enters the following S phase. The synthesis rate of these proteins is also 
assumed to be proportional to the overall protein synthesis rate defined by the set of 
equations (5). Thus, in general if Xp is the mass of either pRb, CycD or CycE: 
 
dXp
dt
=  Xp 
dPs
dt
         (13) 
 
The mechanism implemented in the simulator, whereby pRb releases E2F as soon as nth 
sites are phosphorylated and subsequently E2F catalyzes the conversion of a substrate S 
into a product R, models the whole set of enzymatic reactions that occur upon the 
release of the E2F in the dynamics of the G1m/G1p/S transitions. The pRb/E complex is 
assumed to follow a 1:1 stechiometry, thus the concentration of the enzyme E equals the 
concentration of active pRb molecules. This dynamics is described by the equations: 
 
[E] = PRb [Rb]          (14a) 
d[S]
dt
=  kMM [E] [S]
KMM + [S]
        (14b) 
G1m G1p     if    [S] < Sth,1         (14c) 
G1p S           if    [S] < Sth,2         (14d) 
 
Where [S]0 denotes the initial substrate concentration in the simulator, and Sth,1 and Sth,2 
are two critical S concentrations. The initial substrate concentration [S]0 is assumed to 
be the same for all cells. We remark here that the subdivision of the G1 phase into two 
subphases G1m and G1p has already been considered in our previous model [6] and is 
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also a known experimental fact [42]. Here, however, this subdivision has a precise 
molecular meaning as it defines the transition to CycD destruction and CycE synthesis, 
and moreover both cyclin/CDKs complexes act on the same pRb substrate and this 
reflects realistically the present knowledge on the G1/S checkpoint [35-40]. 
At present, the molecular machinery of the G2/M checkpoint is more obscure than that 
of the G1/S checkpoint, and in that case we assume a much rougher threshold model, 
i.e., threshold crossing happens as soon as the concentration of the proper cyclin/CDK 
complex reaches a critical concentration. For this purpose, we consider a generic cyclin 
X that is synthesized at the beginning of the G2 phase and is destroyed after mitosis.  
The M phase duration has small individual fluctuations associated to the mechanical 
aspects of chromosome condensation and sorting that take place during the M phase. 
Thus:  
 
M _T = M _TM 1+ PHASE_SPREAD·( )       (15) 
 
where M_TM is the mean duration of the M phase, PHASE_SPREAD is a constant, and 
 is a random variable drawn from a uniform distribution in the interval (-1,1). In the 
simulator, the fluctuation of the M phase is determined at cell birth. 
The S phase is regulated differently: its duration is not determined by a checkpoint 
mechanism, but rather by DNA synthesis as described by the set of equations (6). The S 
phase ends when DNA completes the duplication process. 
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4.2 Cell proliferation dynamics and stochastic aspects 
As a cell proceeds along the cell cycle its volume increases and all the cell material is 
roughly doubled in mass, so that after mitosis each daughter cell looks like the mother 
cell at birth.  This also applies to mitochondria, and an approximately linear correlation 
between cell volume and the number of mitochondria has been demonstrated 
experimentally [43]. Mitochondria possess their own DNA that includes the genes for 
some, but not all, mitochondrial proteins. The other mitochondrial proteins are coded 
into the cell’s DNA and imported from the cell cytosol after their expression. 
Mitochondria proliferate by fission, a process that is reminiscent of bacterial 
proliferation, and their number also varies because of mitochondrial fusion and death 
[44, 45]. The proliferation of mitochondria is highly coordinated with cell growth and 
the molecular signals at the basis of the cell/mitochondria synchronization are presently 
under investigation [44, 45]. The regulation of cell volume is not well understood at 
present, however in the simulator we decided to link the cell’s volume to the number of 
mitochondria, i.e., we assume that each cell increases its size to adapt its volume to the 
number of mitochondria in the cytosol (and this part of the model has been completely 
revised with respect to the previous version [6]). 
Mitochondria contain the molecular circuits where the oxydative phosphorylation of 
glucose takes place and produce ATP. On the other hand, the proliferation of 
mitochondria requires energy and hence it depends on the overall energy balance of the 
cell. This establishes an interesting interplay: a cell takes up nutrients from the 
environment for energy production which is the primary task of mitochondria; 
mitochondria utilize part of the energy for their maintenance and proliferation; finally, 
mitochondria give back energy to the cell to accomplish its various tasks. 
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These arguments lead to the following equations:  
 
dM
dt
= C1  dATPp
dt
         (16a) 
dVol
dt
= C2  dM
dt
         (16b) 
 
where M is the number of mitochondria, Vol is the cell volume and C1 and C2 are two 
positive constants. It should be noted that unlike the previous version, the simulation 
program has no upper bound for cell volume and number of mitochondria, so that, at 
least in principle, they can now increase without limit. This means that volume and 
number of mitochondria are controlled by the metabolic network and by the growth 
dynamics, and the eventual stability hints at the correctness of the whole model.  
At mitosis mitochondria are partitioned between the two daughter cells: the partitioning 
follows a binomial distribution, and the reasons for this have already been discussed [6]. 
The volume of the daughter cells is then calculated in accordance with equation (15b): 
 
Vol = Volmin + C2 M 0         (17) 
 
where Volmin is the volume of the nucleus [6] and M0 is the number of mitochondria 
inherited from the mother cell.   
The unequal sharing of cytosol in the daughter cells shows up as an additional source of 
randomness in the partitioning of pRb. The synthesis of pRb has been hypothesized here 
to occur in the nucleus during the G2 phase of the mother cell. In its 
hypophosphorylated form the protein is not released in the cytosol but is retained in the 
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nucleus, bound to the nuclear matrix up to the early G1 phase [46], and thus the amount 
of pRb that the daugther cells receive depends on the distribution of the pRb molecules 
in the nucleus and on the dynamics of the nuclear division. In the simulator we 
implement this mechanism assuming that the nuclear matrix, and hence the associated 
pRb or any other such protein, is split according to a binomial distribution.  
All the other molecules in the cytosol are partitioned proportionally to cell volume, and 
thus their concentration does not change at mitosis, and the randomness of their mass 
splitting depends on the fluctuation of the number of mitochondria. 
 
4.3 Criteria for cell death 
In the present version the model assumes the following criteria for cell death: 
1. the ATP pool falls below a given threshold value ATPmin. This may occur because of 
environmental nutrient deprivation; 
2. the length of the S phase exceeds a given time span S_T. The length of the S phase in 
the simulator depends on the availability of ATP and glutamine, and thus on nutrient 
uptake and utilization. Experiments show that a long-lasting blockade of DNA synthesis 
is not compatible with cell life and the molecular mechanisms leading to cell death 
involve the biochemical networks that form the so-called intra S checkpoints [47-50]; 
3. the length of the G2 phase exceeds a given time span G2_T. This may occur in our 
model because of the G2/M checkpoint when [CycX] does not overcome the threshold 
CycXth. Since [CycX] is a function of protein synthesis and cell volume, this process 
depends on nutrient availability and utilization as well. And indeed, experimental 
observations show that a long-lasting blockade of G2 phase progression leads to cell 
death [47-50]. 
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5. Simulations vs. experimental results 
 
5.1 Growth kinetics 
In its present configuration, the program simulates the growth of proliferating cells 
dispersed in a closed environment. This is equivalent to the growth of tumor blood cells 
in a tissue-culture plate and hence the results of simulations can be directly compared to 
observations. This comparison is all the more direct because the simulator uses 
parameter values estimated from actual experimental data.  
On the whole, the model presented in [6] and extended here is quite complex because it 
considers many biochemical and cellular paths, and a true fit of the model parameters 
cannot be carried out, given the high number of parameters and the scarcity of some key 
experimental data. Thus the model is not optimized – although the parameter estimates 
all lie within reasonable biophysical extremes.  
And yet, even in the absence of a true optimization, the model seems to be quite robust 
and is able to reproduce the observed patterns, e.g., Fig.4 and Fig.5 show some 
simulation outputs and experimental data on the growth of two human leukemia cell 
lines. The simulation covers the same timespan as the observations and there is good 
agreement between the simulated and the observed population dynamics, and the total 
computed ATP mass also fits quite well the experimental data. The only noticeable 
difference between simulations and experimental data is the fast decrease of the number 
of alive cells after the peak, and this probably means that the definition of cell death still 
lacks some relevant detail. However, cellular properties calculated for simulated cells 
using the parameters listed in Tab.1 and in Tab.1 in [6] - to which we refer as the 
“standard” parameters and that give the “standard” growth curve in Fig.1 - match fairly 
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well those observed for real cells (Tab.2). Among them we find the cell size and the 
number of mitochondria per cell that, as mentioned earlier, have been modelled without 
built-in upper and lower bounds. On this basis, we conclude that the model is stable, 
and we discuss this topic further in the next section.  
 
5.2 Cells grow and modify the surrounding environment 
Growth curves such as those shown in Fig.4 and Fig.5 can be subdivided into two 
phases: an initial exponential growth phase followed by a decline in the cell number due 
to cell death. Both phases are well known to be related to the interplay between cells 
and their surrounding environment (see Ref. [51] and references cited therein). Initially, 
nutrients and space are abundant and we observe an exponential growth phase, however 
as cells grow they produce toxic waste products that accumulate in the environment 
ultimately leading to cell death in spite of nutrient availability. In ecological terms the 
size of the environment is related to the so-called carrying capacity [51, 52]. The 
interplay between cells and the environment has been studied both experimentally and 
theoretically by Tracqui et al. [52] using tumor cells that grow attached at the plastic 
surface of culture plates. The environmental accumulation of waste products, mainly 
lactic acid, has been monitored by these authors by means of pH measurements, and it 
has been shown that a peak in the growth curves corresponds to a rapid change in 
environmental pH towards acidic values which are no longer compatible with cell 
survival [52].  
The data shown by Tracqui et al. can be simulated by the simulation program when we 
assume that cells die because of the decrease of environmental pH, and that this process 
does not depend on whether cells grow attached at the plastic surface of culture wells or 
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in suspension. Fig.6 compares the result of a simulation with experimental data reported 
in [53] and redrawn here. To compare experiments with simulated data, time in Fig.6 
has been rescaled in units of doubling time both for real and simulated cells. Doubling 
time is obtained by fitting the exponential growth phase with the equation: 
 
N(t) = N(0)  ekp t          (18) 
 
where N(0) is the initial cell number and kp is the growth rate. Then doubling time  is 
calculated as follows: 
 
 = ln2
kp
      (19) 
 
Fig.6 shows that our model is in good agreement with experimental data as far as cell 
behaviour and environmental changes are concerned. 
 
5.3 Simulations carried out under abnormal growth conditions: predictive capabilities 
of the model 
 
The model parameters listed in Tab.1 have been tuned with a lengthy procedure to 
simulate the growth of proliferating cells in an environment with standard nutrient 
concentration. Experimental growth media are supplemented with foetal bovine serum 
that provides hormones and various growth factors and contain a number of molecules 
that are required for cell growth such as vitamins, proteins, aminoacids, lipids and so 
forth. However, it is well known that tumor cells can grow even in poorer media, 
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though they are sensitive to the deprivation of some key molecules that include glucose, 
glutamine and oxygen. 
To further test our model we have simulated the growth of proliferating cells in an 
environment characterized by low glucose concentrations using the standard parameters 
listed in Tab.1. We developed the model without ever considereding such limiting 
growth conditions and hence these simulations are truly predictive. Fig.7 shows some 
results of these simulations. When the environmental glucose concentration is kept at 
the standard value of 0.9 kg/m3, ATP production (per cell) remains roughly constant 
during growth. However, when the environmental glucose concentration is decreased, 
the model predicts a higher ATP production. Simulated cell in the model transiently 
produce more ATP in low glucose media because of the ATP sensor that has been fully 
described in our previous paper. The ATP sensor was introduced to tune the rates r3, p22 
and p11 shown in Fig.1 and was meant to model phenomenologically both the Pasteur 
and the Crabtree effects [6]. At low glucose concentrations, the ATP production rate 
falls below the standard assumed value (ATP_St, [6]) and turns on the ATP sensor. 
Additional STORE molecules and glutamine molecules are then catabolized resulting in 
a transient overshoot of ATP production (and oxygen consumption) [6].  
As far as we know, this behaviour has never been explored experimentally and therefore 
we carried out experiments on tumor cell growth in glucose-poor media (see also the 
Materials and Methods section). RPMI glucose-free medium has been supplemented 
with 10% FBS that contains approximately 0.9 kg/m3 glucose. Thus the glucose 
concentration in the whole medium is approximately 0.09 kg/m3. Under these 
experimental conditions tumor cells can grow and the ATP production can be measured. 
Experimental data show that in standard medium the ATP per cell remains almost 
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constant throughout the growth process whereas in low glucose medium the ATP 
production is significantly higher, in good agreement with the model predictions. 
Next, we studied the effects of fast modulations of the environmental glucose 
concentrations on cell growth (Fig.8). Both simulations and experiments show 
populations that alternate periods of cell proliferation and death which are out-of-phase 
with glucose fluctuations, although the first peak in population size is higher for 
simulated cells. At the end of the first period of glucose deprivation, the model predicts 
an accumulation of cells in the S phase: this prediction is confirmed by the experimental 
observations. 
The simulations shown in both Fig.7 and Fig.8 agree with the experiments, although the 
quantitative agreement is not perfect. We have carried out a rather extensive exploration 
of the parameter space and we believe that the origin is not due to some bad parameter 
but rather to the missing definition of some biochemical path that finely tunes the cells’ 
behavior. Nevertheless, our model captures the major features of the cells’ behavior in 
these unusual conditions. 
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6. Conclusions and outlook 
 
When dealing with real complex systems, such as animal cells, with a large number of 
parts and a lot of redundancy, it is difficult to decide which parts of the system are 
really necessary and must be kept when developing a viable computational model. 
Several approaches can be followed - and indeed have been followed over the years - to 
model the growth of proliferating cells, and all have advantages and disadvantages. At 
one extreme are the analytical models that use coupled differential equations, and the 
major drawback of these approaches is that the discrete events, that mark a cell’s life 
(such as the duplication of the genome and cell division), cannot be described because 
they lack the required analytical continuity. At the other extreme we find the models 
that try to approach numerically every single known molecular pathway, and still 
cannot describe all the cell’s details because of the huge amount of computational 
resources required for this task [53, 54]. Our approach lies somewhere in between these 
extremes, and we have already shown that it can be used to model quantitatively some 
key aspects of cell metabolism and of cell cycle kinetics [6]. The approach is based on 
the fact that biochemical networks in the cell possess a hierarchical structure [8], and if 
a network has a hierarchical topology then the system dynamics is known to be 
dominated by the network’s hubs [8]. Thus by modelling the hubs of the cell’s 
biochemical networks one should – at least in principle – be able to capture most of the 
information of the cell dynamics. However, there are no general rules to identify these 
hubs and for a cell – with thousands of interconnected biochemical paths – the only way 
is to proceed heuristically.  
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A comparison between our previous model [6] and the model described here shows how 
model refinements lead to a better description especially when abnormal conditions 
require the turning on of seldom used molecular pathways. Indeed our previous model 
compared very favourably with many existing data in three related areas of cell biology: 
metabolism, growth and proliferation. However, that model was unable to account for 
deviations from standard growth conditions, because of the incomplete or missing 
description of certain important paths. The refined model presented here tries to 
overcome several previous limitations, and includes important new details:  
1. the definition of a closed extracellular environment;  
2. the description of biosynthetic pathways such as protein and DNA synthesis;  
3. the description of a minimal biochemical network for the control of the cell cycle;  
4. the description of additional energy-consuming paths;  
5. the inclusion of stochastic aspects that are required to explain the observed 
fluctuations in tumor cell proliferation.  
We believe that the introduction of a network that controls the cell cycle (point 3 above) 
is a major improvement in the model. Indeed, it is well-known that the control of cell 
cycle is rather complex as it is formed by a large number of proteins that act as enzymes 
and/or substrate with complex interactions that lead to a markedly nonlinear behaviour 
[29, 30, 35-41]. These aspects have been already been studied in detail both 
experimentally and theoretically and it has been shown that the network’s dynamics 
includes emergent properties such as limit cycle oscillations and chaos [29, 30, 35-41]. 
However, these results have been obtained mostly in cell-free systems using protein cell 
extracts and it is not clear whether cells share the same dynamics. In particular, the 
chemical oscillations of some proteins of the cyclin network – although evident in the 
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test tube – cannot be directly connected to cell cycle kinetics where proteins are shared 
by the daughter cells and where cyclins are destroyed and regenerated after gene 
expression: processes such as protein degradation and expression are sure to influence 
the dynamics of the network.  
The mechanism that we have included in the simulation program, i.e., the multisite 
protein modification, and in particular multisite phosphorylation of the Rb protein, has 
been shown to account for at least three important, observed, dynamic behaviors:  
1. generation of a biochemical threshold, required to allow a cell to proceed from one 
cell cycle phase to the other;  
2. generation of a time delay in the downstream reactions that span several order of 
magnitude, that is required to transfer biochemical information from the fast enzymatic 
kinetics to the slow cell response;  
3. stability of the dynamics even in presence environmental fluctuations.  
The last remark means that Rb multisite phosphorylation opposes fluctuations, and 
tends to synchronize cells. Thus, the desynchronyzation of cell cycle kinetics, that is an 
experimental evidence [55] and that has been addressed in the previous model [6], is 
greatly reduced and must be restored with the introduction of some additional source of 
randomness. Our description of such processes is still at the phenomenological level, 
and yet we obtain realistic population growth curves (see Fig. 4 and Fig.5 as an 
example). 
We have already remarked that the simulation program uses parameters that are 
estimated from actual data and that for this reason the results of simulations can be 
directly compared with observations. Here we add that during the simulation campaign 
that we have carried out to fine tune some parameter values, we have realized that most 
 43 
parameters are correlated and cannot assume arbitrary values. For example, if cells 
grow quickly because they express great amounts of cyclins or because they take up 
large amounts of nutrients, then they produce more waste products that lead to a fast 
increase of the toxicity of the environment. Thus the actual dimension of the parameter 
space is smaller than the total number of parameters, and parameter tuning is less 
complex than it appears to be at first sight.  
Here we have shown that the model can reproduce quantitatively several aspect of the 
growth of large tumor populations of tumor blood cells and can be used to make 
testable predictions. We also wish to stress that the simulation program has already been 
able to simulate populations of more than a million cells: using a non-optimized version 
of the program we were able to simulate the growth of a cluster of cells that started 
from a single cell and exceeded 1.25 million cells after five days of processing using an 
Apple PowerMac G5. We believe that this marks an important milestone in the 
advancement of the simulation program and we hope that our model will eventually 
help the study of developmental features of tumor cell populations. 
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Figure captions 
 
Figure 1.  Schematic layout of the metabolic network that models cell metabolism and 
its relationship with the extracellular environment. Variables within circles represent 
molecular species and are expressed in units of concentration or mass. Symbols are as 
follows: Gex = external glucose concentration, Gin = intracellular glucose 
concentration, G6P = glucose-6-phosphate concentration, STORE = mass of glucose 
stored in the form of glycogen, Ac.Lat.ex = environmental lactic acid concentration, 
Ac.Lat.in = intracellular lactic acid concentration, Aex = environmental glutamine 
concentration, Ain = intracellular glutamine concentration, ATPp = pool of ATP 
molecules concentration, O2 = oxygen concentration, H+ = mass of intracellular 
protons, Proteins = mass of intracellular proteins, DNA = relative mass of DNA 
(normalized to 1 for the whole genome). Rates are represented by squares. The dashed 
and dotted circuits represent the ATP and Oxygen sensors, respectively, and have been 
described previously [6]. The dashed-and-dotted circuit named “Cell Cycle 
Checkpoints” represent the molecular circuit of cell cycle control that has been modeled 
on the basis of previous studies on the dynamics of the allosteric effect (see Refs. [33, 
34] and equations 11-14 for details).  is the cell membrane electric potential that has 
been used to calculate the energy costs for intracellular proton dissipation (see equations 
8-9 for details). The calculation of the global energy cost also requires the rates v_Mit, 
v_P and v_DNA that model ATP consumption for mitochondria maintenance, protein 
synthesis and DNA synthesis, respectively.  
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Figure 2.  Scheme of the molecular interactions that have been considered in the model 
of the G1/S transition of the cell cycle. The retinoblatoma protein (pRB) has been 
supposed to form a complex with an enzyme E and carries 16 putative phosphorylation 
sites. The pRB-E complex is synthesized in the G2 phase and it is partitioned at random 
between the daughter cells at mitosis. At the beginning of the G1m phase the cyclin D 
protein (CycD) is expressed and it phosphorylates the pRB-E complex upon rapid 
association with specific cyclin-dependent-kinases [35-40]. Phosphoryl groups added to 
the pRB-E complex are represented graphically by means of black circles. The 
phosphorylation event is assumed to occur following the reversible bimolecular 
interaction between cyclin D and the pRb complex: a detailed study has shown that the 
precise mechanism of pRb phosphorylation is irrelevant with respect to the dynamics of 
the system’s response [34]. Upon partial phosphorylation of the pRb, a fraction of E 
molecules are released and catalyze a reaction whereby a substrate S is converted into a 
product P. When the concentration of S falls below the threshold Sth,1  (see equations 13) 
two paths are activated the expression of the cyclin E protein (CycE) is activated and 
this marks the progression of the cell from the G1m phase to the following G1p. CycE  
participates to pRb phosphorylation upon istantaneous association with specific cyclin-
dependent-kinases and leads to the hyperphosphorylation of the pRb with full E 
detachment. When the concentration of S falls below the threshold Sth,2 (see equations 
13) the cell progresses to the S phase. At the end of the G1m and of the G1p phases 
CycD and CycE, respectively, are destroyed by proteolytic degradation that is assumed 
to occur faster than the considered reaction kinetics. The enzymatic reaction catalized 
by E is assumed to model phenomenologically the reactions controlled by the 
transcription factor E2F that associates to pRb in real cells. The nature of pRb 
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phosphorylation naturally introduces a threshold and a time delay in the reaction 
catalized by E with characteristic times comparable with the cell progression through 
the various cell cycle phases (see also [33, 34] for a detailed biophysical description).  
 
Figure 3.  Simulation of cell cycle kinetics and its relationships with the expression of 
key molecular components of cell cycle control. A: kinetics of the cell cycle transitions 
from one phase to the other for a simulated cell. Cell cycle phases are as follows: 1 = 
G1m, 2= G1p, 3 = S, 4 = G2 and 5 = M. B-E: these graphs show the variation of cyclin 
X, D and E and of the pRb during the same time span as panel A (see text). Finally, 
panel F shows the fraction of hypersphosphrylated pRb that has been calculated using 
equations (11). Notice that in the present model the oscillations in cyclin expression 
(and of other molecular components of the cyclin network), that have indeed been 
observed experimentally, are the result of protein expression and degradation in 
successive cell cycles rather than the result of complex nonlinear interactions between 
molecules. As far as we know, no models of cyclin oscillations have taken into account 
the intermittent protein expression and degradation through successive cell cycles as the 
driving force of their oscillatory behaviour. More realistically, the two aspects are 
probabily integrated in real cells. 
 
Figure 4.  Simulation of cell growth and death in a limited environment. In both panels, 
data are expressed as cell density vs. time. Upper panel: simulation outputs for different 
values of the parameters described in this paper. The curves marked as run120 show the 
simulation outputs obtained with the parameter values listed in Tab.1 and in Tab.1 of 
Ref. [6] and which we call “standard”. Lower panel: experimental growth curves 
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measured for the two human leukemia cell lines MOLT3 and Raji following the 
procedures described in the Experimental section. 
 
Figure 5.  Amount of the ATP pool in simulated and real cells in growth assays. Upper 
panel: simulation outputs. Symbols are the same as in Fig.4 for proper comparison. The 
grey dashes represent the SD calculated around mean values for the simulated 
populations. Lower panel: experimental results obtained with the human leukemia cell 
lines MOLT3 and Raji following the procedures described in the Experimental section. 
 
Figure 6. While cells grow they modify the surrounding environment. This picture 
shows the results of simulations compared to actual data described in [52], and the 
relationships between cell concentration and environmental pH at different times during 
the growth assay. In both panels, the cell density has been normalized with respect to 
the initial cell concentration C(0). Time has also been rescaled in units of cells’ 
doubling time to compare the data obtained with fast growing simulated cells and slow 
growing real tumor cells (see the text for details). Upper panel: simulation outputs. 
Lower panel: experimental results redrawn from [52]. 
 
Figure 7. Predictive potential of the model: ATP production by cells growing in low 
glucose environments. A: amount of the ATPp calculated for cells in simulations 
carried out with the parameters’ values listed in Tab.1 for different concentrations of 
external glucose. The symbol +G refers to the standard glucose concentration of 0.9 
kg/m3, which is the typical glucose concentration in complete culture media 
supplemented with FBS. After the startup phase of the program, that allows the 
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concentrations of all the considered molecular species to settle at equilibrium values, 
the environmental glucose concentration has been reduced to 10% or to 7.5% of the 
standard value. B: experimental resulta obtained with MOLT3 cells in complete 
medium (+G) and in two independent experiments where cells have been grown in 
glucose-free RPMI medium supplemented with 10% foetal bovine serum (FBS). 
Glucose is present in FBS with an approximate concentration of 0.9 kg/m3, but this may 
vary in different FBS batches. Thus in these two experiments the final environmental 
glucose concentration is approximately 0.09 kg/m3. C and D: cumulative ATP for 
simulated cells (panel C) and real cells (panel D) (the cumulative value has been 
calculated from the curves in panels A and D with a simple integration: ATP(t)  dt
0

 ). 
 
Figure 8. Predictive potential of the model: growth of tumor cells in environments 
subjected to cycles of glucose deprivation. A and B: Time-dependent variations of 
glucose concentrations in the environment of simulated cells (A) and of real cells (B). 
The concentration of environmental glucose for real cells has been estimated as 
described in the caption of Fig.7. C and D: growth curves (cell density vs. time) for 
simulated (panel C) and real (panel D) cells. E: cell cycle phase distribution for 
simulated cells during the first cycle of environmental glucose deprivation. Simulation 
outputs show an accumulation of cells in the S phase and a strong reduction of cells in 
the G2/M phases. F: raw flow cytometry data of cell cycle distribution of real cells 
during the first cycle of environmental glucose deprivation. Data have been collected as 
described in the Experimental section. The accumulation of the cells in the early S 
phase is evident (arrow) as well as the reduction of the cells in the G2/M phases, 
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although both data sets do not match quantitatively the simulation outputs. However, 
the qualitative pattern is well predicted by the model. 
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Table 1. Model parameters for the standard simulation that are either modified or new 
with respect to those listed in reference [6]. 
 
Symbol Value Units Meaning References 
Vmax_A 1x10
-9 kg s-1 m-
2 
Maximum rate of glutamine transport [12] 
KmA 0.0238 kg m
-3 Michaelis-Menten constant of 
glutamine transport 
[56] 
Vmax_AL 9.58x10
-8 kg s-1 m-
2 
Maximum rate of lactic acid transport [15, 57, 58] 
KmAL 0.4053 kg m
-3 Michaelis-Menten constant of lactic 
acid transport 
[15, 57, 58] 
Vrif -0.021 V Cell membrane potential in standard 
conditions 
This paper (see 
the text for 
details) 
H_Peff 0.1  Phenomenological constant describing 
the inverse of the efficiency of proton 
pumps 
This paper (by 
data fitting) 
DH 1.5x10
-18 m3 s-1 Effective proton diffusion constant 
(assuming a plasma membrane 
thickness of 10 nm) 
[59] 
out 0.19953 kg m-3 Buffering capacity of the environment [21] 
p3 7x10
-20 kg s-1 Rate of glutamine consumption for 
protein and DNA synthesis 
This paper (by 
data fitting) 
KmP 9x10
-17 kg Michaelis-Menten constant of ATP 
utilization in protein synthesis 
This paper (by 
data fitting) 
KmDNA 8x10
-18 kg Michaelis-Menten constant of ATP 
utilization in DNA synthesis 
This paper (by 
data fitting) 
DNA 0.008  Fraction of the total ATP production 
rate utilized for DNA synthesis 
This paper (by 
data fitting) 
DNA_MAX 
_SPREAD 
0.1  Maximum spread of the fluctuations in 
the DNA synthesis duration 
This paper (by 
data fitting) 
N 16  Maximum number of phosphorylation 
sites on pRb 
[38] 
l 10  Number of sites that must be 
phosphorylated for pRb activation 
[38] 
KRb 10
-6 M-1 Equilibrium constant for  [60] a 
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phosphorylation/dephosphorylation 
process on pRb 
pRb 1.5x10-2  Fraction of proteins  which is pRb This paper (by 
data fitting) 
CycD 7x10-3  Fraction of proteins  which is cyclin D This paper (by 
data fitting) 
CycE 10-3  Fraction of proteins  which is cyclin E This paper (by 
data fitting) 
CycX 8x10-3  Fraction of proteins  which is cyclin X This paper (by 
data fitting) 
S 10-3 M Substrate concentration for the 
downstream Michaelis-Menten 
reaction controlled by pRb 
[33, 34] 
kMM 10
4 s-1 Rate of S molecules consumption [33, 34] 
KMM 10
-3 M Michaelis-Menten constant of S 
molecules consumption 
[33, 34] 
Sth1 0.8  Fraction of the S concentration that 
defines the threshold for the G1m/G1p 
transition 
This paper (by 
data fitting) 
Sth2 0.05  Fraction of the S concentration that 
defines the threshold for the G1p/S 
transition 
This paper (by 
data fitting) 
CycXth 8x10
-17 kg Amount of cyclin X that defines the 
threshold for the G2/M transition 
This paper (by 
data fitting) 
C1 3x1016 kg-1 Phenomenological constant for the 
growth of mitochondria 
This paper (by 
data fitting) 
C2 2x10-18 m3 Phenomenological constant for the 
increase of the cell volume 
This paper (by 
data fitting) 
vMit 4x10
-22 kg s-1 Rate of ATP consumption for 
mitochondria maintenance 
This paper (by 
data fitting) 
ATPmin 1.5x10
-15 kg Minimum ATP amount for cell 
survival 
This paper (by 
data fitting) 
S_T 55000 s Maximum duration of the S phase [6] 
G2_T 25200 s Maximum duration of the G2 phase [6] 
M_TM 1800 s Mean duration of the M phase [6] 
PHASE_SPREAD 0.5  Maximum spread for the fluctuations in 
the M phase duration 
This paper (by 
data fitting) 
a value measured for the equilibrium between ATP and cyclin-dependent kinases. 
 59 
 
Table 2. Estimated parameters for the simulated standard tumor cell population 
compared to experimental measurements. All values have been taken during 
exponential growth. 
 
 
Parameter 
 
 
Simulated 
 
Experimental 
 
Ref. 
 
Growth rate a 
(hours-1) 
 
 
0.035 
 
0.0304 b 
0.0352 c 
 
This work 
 
 
Doubling timea 
(hours) 
 
 
19.8 
 
22.8 b 
19.7 c 
 
This work 
 
 Average Min Max Mean±SD  
Cell cycle 
distribution 
(%) 
 
G1 
S 
G2/M 
 
 
 
 
 
52.5 
34.5 
12.9 
 
 
 
 
 
48.4 
30.5 
7.3 
 
 
 
 
 
59.3 
40.5 
17.7 
 
 
 
 
54.4 ± 2.2 a 
27.5 ± 5.8 a 
16.4 ± 1.7 a 
 
 
 
 
 
[6] 
 
  
ATP/Cell 
(10-15 g) 
 
 
5.47 
 
 
 
5.37 
 
5.55 
 
5.76 ± 0.73 a 
4.32 ± 0.72 b 
 
 
This work 
 
Radius 
(μm) 
 
 
5.02 
 
4.82 
 
5.30 
 
7.5 
 
[61] 
 
Volume 
(μm3) 
 
 
530 
 
471 
 
623 
 
700-1500 
 
[61, 62] 
 
Mitochondria/Cell 
 
 
220.4 
 
190.6 
 
266.9 
 
83-677 d 
 
[63] 
 
aThe growth rate for both simulated and experimental cell populations was calculated by 
exponential fitting of growth curves. The doubling time was then calculated as 
log2/(growth rate) 
bData measured for the MOLT3 human T lymphoblastoid cell line 
cData measured for the Raji human B lymphoblastoid cell line 
dRange of the number of mitochondria observed in different cell types 
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